Results of a prospective, randomized, double-blind, double-dummy, Phase 3 study comparing denosumab with zoledronic acid for the treatment of breast cancer patients with bone metastases
暂无分享,去创建一个
Y. Fujiwara | A. Stopeck | G. Steger | J. Body | A. Lipton | M. Viniegra | R. Dansey | M. Fan | Jun Susie | Braun Ada